BARRATT JOHN P

CIK 00012705291 companyTORONTO, A6

SEC Profile

Transactions

Companies

Filings

CIK

0001270529

Recent Transactions

22 trades

Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2015-04-27−918,033→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2015-04-27−592,593→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock
2015-04-27$0.00/sh+5,874,162→ 5,874,162 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2015-04-27−1,810,345→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2015-04-27−2,553,191→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (Right to Buy)
2014-10-06−35,714→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock
2014-10-06$0.00/sh+35,714→ 35,714 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2013-10-31+1,810,345→ 1,810,345 total
Award
GENEREX BIOTECHNOLOGY CORP
Common stock purchase option (right to buy)
2013-06-06+592,593→ 592,593 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2013-04-01+2,553,191→ 2,553,191 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2012-06-19+918,033→ 918,033 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2011-03-25+500,000→ 500,000 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2010-03-08+100,000→ 100,000 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20+70,000→ 70,000 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20+100,000→ 100,000 total
Disposition to Issuer
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20−35,714→ 0 total
Disposition to Issuer
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20−70,000→ 0 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20+35,714→ 35,714 total
Disposition to Issuer
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20−100,000→ 0 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock
2006-05-30+150,000→ 150,000 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Options
2005-04-05+100,000→ 100,000 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Options
2003-10-30+70,000→ 140,000 total

Companies

GENEREX BIOTECHNOLOGY CORP
Director

Recent Filings

Address

C/O GENEREX BIOTECHNOLOGY CORPORATION 33 HARBOUR SQUARE, SUITE 202

TORONTO, A6, M5J 2G2

View on SEC.gov